#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vernal keratoconjunctivitis Alagille syndrome Sjogren's syndrome B precursor type acute leukaemia Stargardt's disease Hypereosinophilic syndrome Mantle cell lymphoma stage IV Uveal melanoma Neuroendocrine tumour Cystic fibrosis lung Gastrooesophageal cancer Aplastic anaemia Leukaemia Breast angiosarcoma metastatic Restless legs syndrome More trials…

    Learn about Rare Diseases

    Adrenogenital syndrome Rosai-Dorfman syndrome – Trials in Disease Phenylketonuria Sjogren’s syndrome – Trials in Disease Angelman’s syndrome – Life with Disease Niemann-Pick disease Alport’s syndrome Pulmonary sarcoidosis Basal cell naevus syndrome Waldenstrom’s macroglobulinaemia recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ursodoxicoltaurine Eletriptan Argipressin Tolebrutinib Nitrous Oxide Loperamide Hydrochloride Art0380 Mesilate Doxycycline Hyclate Alemtuzumab GSKVX000000044501 Zoledronic Acid Eptacog Beta (Activated) Msv-Allo Fenoterol Hydrobromide Skin Autograft Vanzacaftor Gliclazide Lisinopril Dihydrate Belumosudil Mesilate Pralsetinib More therapies…

    Learn about Your Condition

    Cirrhosis alcoholic Foot deformity Mantle cell lymphoma stage IV Ectopic pregnancy Epithelioid sarcoma Hyperoxaluria Tachypnoea Breast cancer metastatic Sickle cell anaemia Skin cancer Dementia Metastatic gastric cancer Macular oedema End stage renal disease Anal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pia Fondazione Di Culto E Religione Card G Panico

Pia Fondazione Di Culto E Religione Card G Panico

Via Pio X 4, Tricase, 73039, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Comparing Daraxonrasib Alone or Combined with Gemcitabine and Paclitaxel Albumin‑Bound vs Standard Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Austria Belgium Denmark France Germany Italy +5

  • Study of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Azd0901
    • Zolbetuximab
    • Capecitabine
    Belgium France Germany Hungary Italy The Netherlands +2

  • Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • 5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE
    Bulgaria Czechia France Hungary Italy Poland +3

  • A study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer’s disease

    Recruiting

    4 1
    Investigated Diseases:
    • Agitation
    • Dementia Alzheimer’s type
    Czechia Germany Italy Poland Slovakia Spain

  • A Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Fluorouracil
    Belgium Denmark France Germany Italy The Netherlands +2

  • Comparing irinotecan plus cetuximab with trifluridine and tipiracil plus bevacizumab for patients with metastatic colorectal cancer as third line treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Bevacizumab
    Italy

  • A Study of ACP-204 Tartrate for Adults With Lewy Body Dementia Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • A Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • A Study of Fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.

    Recruiting

    2 1
    Investigated Drugs:
    • 5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE
    Bulgaria Czechia France Hungary Italy Poland +3

  • Treatment with trastuzumab deruxtecan, capecitabine and bevacizumab for patients with HER2-positive metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Bevacizumab
    • Capecitabine
    France Germany Italy Spain
1 2 3 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!